Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor
β Scribed by Akira Kawai; Masayuki Noguchi; Yasuo Beppu; Ryohei Yokoyama; Kiyoshi Mukai; Setsuo Hirohashi; Hajime Inoue; Hisatoshi Fukuma
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 632 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background and objectives: This study was undertaken to study the behavior of superficial soft tissue sarcomas (sts) and determine the factors related to prognosis. ## Methods: The clinical records of 105 adults (56 men, 49 women, mean age: 56.4 years) were retrospectively analyzed. univariate
The p16 INK4A /CDKN2/MTS1 gene encodes a specific inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. This study investigates p16 INK4A gene status and expression in mesenchymal tumours, in particular soft tissue sarcomas (STSs). Employing non-radioactive polymerase chain reaction-single strand co
## Background: The authors determined the flow cytometric (fcm) dna characteristics of 53 benign tumors and 132 malignant (71 primary, 61 recurrent) soft tissue sarcomas to investigate their heterogeneity and to evaluate the prognostic values of dna ploidy status and s-phase fraction (spf). ## Met
## Abstract ## BACKGROUND Little is known about the expression of receptor tyrosine kinases in adult soft tissue sarcomas (STS). In the current study, the authors analyzed the expression of epidermal growth factor receptor (EGFR), __ERBB2__, and __KIT__ in 281 patients with STS who were treated in